NMT2 antibody

Ref. 3D-10R-5016

Produktinformation

• Name: NMT2 antibody

Beschreibung

The NMT2 antibody is a highly specialized antibody that targets activated atypical hemolytic cells. It has been extensively studied in the field of Life Sciences and has shown promising results in inhibiting the growth factor signaling pathway. The NMT2 antibody works by binding to epidermal growth factor receptors, preventing their activation and subsequent downstream signaling events. This inhibition leads to the dephosphorylation of key proteins involved in cell proliferation and survival, ultimately resulting in the suppression of tumor growth.

Furthermore, the NMT2 antibody has been engineered as a chimeric protein, combining the specificity of monoclonal antibodies with the stability and functionality of hybridization technology. This allows for enhanced binding affinity and prolonged half-life in circulation, ensuring maximum efficacy.

In addition to its anti-cancer properties, the NMT2 antibody has also shown potential therapeutic effects in autoimmune diseases. By targeting autoantibodies and interfering with their interaction with arachidonic acid, this antibody can modulate immune responses

• Marke: Biosynth